180 related articles for article (PubMed ID: 20606740)
1. Plasma gelsolin protein: a candidate biomarker for hepatitis B-associated liver cirrhosis identified by proteomic approach.
Marrocco C; Rinalducci S; Mohamadkhani A; D'Amici GM; Zolla L
Blood Transfus; 2010 Jun; 8 Suppl 3(Suppl 3):s105-12. PubMed ID: 20606740
[TBL] [Abstract][Full Text] [Related]
2. Peroxiredoxin 2: a potential biomarker for early diagnosis of hepatitis B virus related liver fibrosis identified by proteomic analysis of the plasma.
Lu Y; Liu J; Lin C; Wang H; Jiang Y; Wang J; Yang P; He F
BMC Gastroenterol; 2010 Oct; 10():115. PubMed ID: 20939925
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial peptide ligand libraries to discover liver disease biomarkers in plasma samples.
D'Amici GM; Timperio AM; Rinalducci S; Zolla L
Methods Mol Biol; 2012; 909():311-9. PubMed ID: 22903724
[TBL] [Abstract][Full Text] [Related]
4. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus.
Cao X; Shang QH; Chi XL; Zhang W; Xiao HM; Sun MM; Chen G; An Y; Lv CL; Wang L; Nan YM; Chen CY; Tan ZN; Liu XE; Zhuang H
World J Gastroenterol; 2020 Mar; 26(10):1067-1079. PubMed ID: 32205997
[TBL] [Abstract][Full Text] [Related]
5. Comparative serum proteomic analysis of patients with acute-on-chronic liver failure: alpha-1-acid glycoprotein maybe a candidate marker for prognosis of hepatitis B virus infection.
Ren F; Chen Y; Wang Y; Yan Y; Zhao J; Ding M; Zhang J; Jiang Y; Zhai Y; Duan Z
J Viral Hepat; 2010 Nov; 17(11):816-24. PubMed ID: 20002297
[TBL] [Abstract][Full Text] [Related]
6. [Plasma proteome analysis of chronic hepatitis B patients with different stages of liver fibrosis].
Jia XF; Lu W; Yin L; Yuan ZH; Zhang LJ; Zhang ZQ
Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):659-63. PubMed ID: 23207229
[TBL] [Abstract][Full Text] [Related]
7. A novel noninvasive algorithm for the assessment of liver fibrosis in patients with chronic hepatitis B virus infection.
Zhu MY; Zou X; Li Q; Yu DM; Yang ZT; Huang D; Chen J; Gong QM; Zhang DH; Zhang Y; Chen L; Chen PZ; Zhang XX
J Viral Hepat; 2017 Jul; 24(7):589-598. PubMed ID: 28130852
[TBL] [Abstract][Full Text] [Related]
8. A Two-layer Model to Identify Hepatitis B Virus Related Chronic Hepatitis and Liver Cirrhosis Based on Plasma microRNA Biomarkers.
Hou T; Wang Z; Jin W; Liu C; Sun X; Li N; Zhang Y; Chen Y; Zhang W; Li Y
Comb Chem High Throughput Screen; 2017; 20(2):123-132. PubMed ID: 28000564
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.
Zeng DW; Dong J; Liu YR; Jiang JJ; Zhu YY
World J Gastroenterol; 2016 Aug; 22(29):6663-72. PubMed ID: 27547009
[TBL] [Abstract][Full Text] [Related]
10. Serum keratin-18 fragments as cell death biomarker in association with disease progression and prognosis in hepatitis B virus-related cirrhosis.
Cao Z; Chen L; Li J; Liu Y; Bao R; Liu K; Yan L; Ding Y; Guo Q; Xiang X; Xie J; Lin L; Xie Q; Bao S; Wang H
J Viral Hepat; 2019 Jul; 26(7):835-845. PubMed ID: 30974482
[TBL] [Abstract][Full Text] [Related]
11. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
Chu CM
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
[TBL] [Abstract][Full Text] [Related]
12. Differential proteomic analysis of plasma-derived exosomes as diagnostic biomarkers for chronic HBV-related liver disease.
Ye B; Shen Y; Chen H; Lin S; Mao W; Dong Y; Li X
Sci Rep; 2022 Aug; 12(1):14428. PubMed ID: 36002595
[TBL] [Abstract][Full Text] [Related]
13. Novel serum biomarker candidates for liver fibrosis in hepatitis C patients.
Gangadharan B; Antrobus R; Dwek RA; Zitzmann N
Clin Chem; 2007 Oct; 53(10):1792-9. PubMed ID: 17702858
[TBL] [Abstract][Full Text] [Related]
14. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
15. Circulating proteomic panels for diagnosis and risk stratification of acute-on-chronic liver failure in patients with viral hepatitis B.
Sun Z; Liu X; Wu D; Gao H; Jiang J; Yang Y; Wu J; Gao Q; Wang J; Jiang Z; Xu Y; Xu X; Li L
Theranostics; 2019; 9(4):1200-1214. PubMed ID: 30867825
[TBL] [Abstract][Full Text] [Related]
16. Serum proteomic MRM identify peptide ions of transferrin as new fibrosis markers in chronic hepatitis B.
Xu MY; Qu Y; Jia XF; Wang ML; Liu H; Wang XP; Zhang LJ; Lu LG
Biomed Pharmacother; 2013 Sep; 67(7):561-7. PubMed ID: 23639231
[TBL] [Abstract][Full Text] [Related]
17. Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver Cirrhosis.
Wu C; Liu L; Zhao P; Tang D; Yao D; Zhu L; Wang Z
Gut Liver; 2015 Sep; 9(5):665-71. PubMed ID: 25963079
[TBL] [Abstract][Full Text] [Related]
18. Novel biomarker candidates to predict hepatic fibrosis in hepatitis C identified by serum proteomics.
Yang L; Rudser KD; Higgins L; Rosen HR; Zaman A; Corless CL; David L; Gourley GR
Dig Dis Sci; 2011 Nov; 56(11):3305-15. PubMed ID: 21590334
[TBL] [Abstract][Full Text] [Related]
19. Identification of plasma lncRNA-ATB levels in hepatitis B virus-related cirrhosis and non-cirrhotic chronic hepatitis B patients.
Shoraka S; Mohebbi SR; Hosseini SM; Asadzadeh Aghdaei H; Zali MR
Virus Res; 2021 Oct; 303():198503. PubMed ID: 34331990
[TBL] [Abstract][Full Text] [Related]
20. Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection.
Cao Z; Li Z; Wang Y; Liu Y; Mo R; Ren P; Chen L; Lu J; Li H; Zhuang Y; Liu Y; Wang X; Zhao G; Tang W; Xiang X; Wang H; Cai W; Liu L; Zhu C; Bao S; Xie Q
J Viral Hepat; 2017 Nov; 24 Suppl 1():57-65. PubMed ID: 29082644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
